Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Apollomics, Astrazeneca, Biogen, Hightide, Innovent, QL Biopharmaceutical, Ractigen, Telix.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Imugene, Telix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biovaxys, Innovo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinogen, Prota, Xgene.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Neuren Pharmaceuticals.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Biogen, Otsuka.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Immutep, Kazia, Verastem

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Zhiyu.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Actinogen, Douglass, Eisai, Encell, Huadong, Innovent, Immutep, Recce, Sun Pharmaceutical, Takeda, Tiumbio.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Clover, Carsgen, Daewoong, Hightide, Hutchmed, Takeda.